Connor Clark & Lunn Investment Management Ltd. Has $433,000 Position in Cardiovascular Systems, Inc. (NASDAQ:CSII)

Connor Clark & Lunn Investment Management Ltd. grew its position in Cardiovascular Systems, Inc. (NASDAQ:CSIIGet Rating) by 229.6% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 30,168 shares of the medical device company’s stock after buying an additional 21,014 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned 0.07% of Cardiovascular Systems worth $433,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in CSII. Nisa Investment Advisors LLC raised its position in shares of Cardiovascular Systems by 54.3% in the 1st quarter. Nisa Investment Advisors LLC now owns 3,495 shares of the medical device company’s stock valued at $79,000 after buying an additional 1,230 shares in the last quarter. Signaturefd LLC increased its position in Cardiovascular Systems by 8,110.3% during the 1st quarter. Signaturefd LLC now owns 2,381 shares of the medical device company’s stock worth $54,000 after purchasing an additional 2,352 shares in the last quarter. Simplex Trading LLC increased its position in Cardiovascular Systems by 35.3% during the 1st quarter. Simplex Trading LLC now owns 9,971 shares of the medical device company’s stock worth $225,000 after purchasing an additional 2,602 shares in the last quarter. Envestnet Asset Management Inc. acquired a new position in Cardiovascular Systems during the 1st quarter worth approximately $833,000. Finally, Russell Investments Group Ltd. increased its position in Cardiovascular Systems by 17.2% during the 1st quarter. Russell Investments Group Ltd. now owns 48,564 shares of the medical device company’s stock worth $1,096,000 after purchasing an additional 7,137 shares in the last quarter. 91.72% of the stock is currently owned by institutional investors and hedge funds.

Cardiovascular Systems Trading Up 0.3 %

Shares of NASDAQ CSII opened at $14.67 on Friday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 5.20 and a current ratio of 6.22. Cardiovascular Systems, Inc. has a 52-week low of $12.26 and a 52-week high of $27.52. The firm has a 50 day moving average price of $13.86 and a two-hundred day moving average price of $14.95. The stock has a market cap of $614.41 million, a P/E ratio of -14.67 and a beta of 0.88.

Analyst Upgrades and Downgrades

Separately, StockNews.com assumed coverage on shares of Cardiovascular Systems in a research report on Wednesday, October 12th. They set a “hold” rating for the company.

Cardiovascular Systems Profile

(Get Rating)

Cardiovascular Systems, Inc, a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.

Featured Stories

Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems, Inc. (NASDAQ:CSIIGet Rating).

Institutional Ownership by Quarter for Cardiovascular Systems (NASDAQ:CSII)

Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.